VIPPSTAR-G1 Digital Early Intervention for Visual Impairment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-42
SponsorUniversità degli Studi di Brescia

About this trial

Visual impairment in infancy is associated with significant risks for neurodevelopmental impairment. Early intervention based on enriched visual and multisensory experiences may promote neuroplasticity and improve developmental outcomes, but implementation of intensive interventions in routine clinical practice remains challenging. The VIPPSTAR-G1 study evaluates a caregiver-mediated digital intervention delivered through a dedicated platform designed to support visual and neurodevelopmental functions in infants at risk of or with visual impairment, within a framework that promotes and strengthens the parent-child/caregiver-child relationship.

This multicenter, multinational, single-blind randomized controlled trial will enroll 102 newborns at risk of visual impairment and an additional exploratory pilot subgroup of 48 infants and toddlers with established visual impairment. Participants will be randomized to receive either the VIPPSTAR digital intervention plus standard care or standard care alone. Outcomes include visual acuity, smooth pursuit, additional neuro-ophthalmological functions, neurodevelopmental measures, adaptive functioning, language development, parental stress, quality of life, and feasibility of the digital intervention.

Eligibility criteria

Qualifiers

Gestational age ≤32 weeks OR full-term/newborns>32 weeks of age with neonatal distress (Apgar ≤5 at 10 minutes)

NAVEG score ≥3

3 abnormal signs at ATNAT neurological examination OR Abnormal cranial ultrasound findings OR Abnormal MRI findings

Disqualifiers

Epileptic encephalopathy

Parents unable to understand local language

Age ≤42 months

Diagnosis of peripheral or cerebral visual impairment

Trial design

Treatments tested in this trial

  • VIPPSTAR Digital Early Intervention
  • Standard Clinical Care

Treatment groups

150 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Università degli Studi di Brescia

Lead sponsor

ASST Spedali Civili of Brescia, Brescia, Italy

Collaborator

Department of Development and Regeneration, KU Leuven, Leuven, Belgium

Collaborator

Centrul Republican de Reabilitare pentru Copii, Moldova

Collaborator

Vestibular and oculomotor laboratory, Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands

Collaborator

National Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy

Collaborator

LIGHT Center, Brescia, Italy

Collaborator

EODYNE SYSTEMS SL, Barcelona, Spain

Collaborator

Department of Psychology and Cognitive Science, University of Trento, Rovereto, Italy

Collaborator

Department of Brain and Behavioral Sciences University of Pavia, Pavia, Italy

Collaborator

Child Neurology and Psychiatry Unit IRCCS Mondino Foundation, Pavia, Italy

Collaborator

VIPPSTAR Consortium

Collaborator